The National University of Singapore Centre for Additive Manufacturing (AM.NUS) was launched recently—at the Additive Manufacturing Healthcare Summit—by Mr Amrin Amin, Parliamentary Secretary, Ministry of Home Affairs and Ministry of Health. The Summit was jointly organised by the National Additive Manufacturing Innovation Cluster (NAMIC) and NUS Enterprise.

Dr Ho Chaw Sing, Managing Director NAMIC (left) with Mr Amrin Amin at the launch of AM.NUS. Photo credit: NAMIC

Dr Ho Chaw Sing, Managing Director NAMIC (left) with Mr Amrin Amin at the launch of AM.NUS. Photo credit: NAMIC

A collaborative effort spearheaded by NAMIC and the Singapore Economic Development Board (EDB)—with an initial funding of SGD18 million from NUS, NAMIC and EDB—AM.NUS will focus on developing and applying ground-breaking additive manufacturing (AM) technology in the biomedical and healthcare fields. Leveraging on the university’s multi-disciplinary expertise—from the Yong Loo Lin School of Medicine, Faculty of Engineering, Faculty of Science, Faculty of Dentistry and School of Design and Environment—the centre will aid in boosting the university’s capabilities in the field of AM-enabled biomedical technology.

“The NUS Centre for Additive Manufacturing will play a critical role in supporting Singapore’s vision of becoming a leading AM hub. Through this inter-faculty pooling of expertise, we hope to boost technology capabilities as well as advance intellectual property development and commercialisation of AM-enabled biomedical technologies,” remarked Professor Jerry Fuh Ying-Hsi, Co-Director of AM.NUS, who is the Thrust Lead of Restorative Repair & Implants and from the Department of Mechanical Engineering at the NUS Faculty of Engineering.

MOU signing ceremony between AM.NUS and the four industry partners. Photo credit: NAMIC
MOU signing ceremony between AM.NUS and the four industry partners. Photo credit: NAMIC

Propelling healthcare delivery


Associate Professor Wilson Wang Ee Jen, Co-Director, AM.NUS, who is also from the NUS Yong Loo Lin School of Medicine, further echoed that the end goal of the facility is “to introduce new innovative products to the market, which can improve patient outcomes and healthcare delivery.”

AM.NUS will drive AM R&D in the biomedical sector along the following key thrusts:
1) Developing surgical instruments, simulators and prosthetics
2) 3D Printing-enabled customised medicine
3) Bio-printing for tissue repair
4) Restorative repairs and implants
5) Oral health and craniofacial applications

According to Dr Ho Chaw Sing, Managing Director NAMIC, AM.NUS—which is also a cluster founding member, alongside NTU’s Singapore Centre for 3D Printing and SUTD’s Digital Manufacturing and Design Research Centre—will play a vital role in NAMIC’s translational research and industry adoption efforts, further strengthening Singapore’s efforts to become a global 3D printing technology hub. “As the industrialisation of 3D printing gains momentum, our goal is help the sector achieve better patient outcomes, addressing the needs of our bio-medical and patient community with cost-effective and personalised healthcare solution,” he expressed.

New industry collaborations in the making


AM.NUS will work closely with industry partners—Creatz3D, Dou Yee Enterprises, Forefront Additive Manufacturing and Osteopore International—to develop and transfer AM technologies for biomedical applications.


“AM.NUS will bring together NUS technologies with industry expertise, enabling the accelerated translation of NUS technologies into innovative healthcare products and services. The Centre is already working on a total of 17 collaborative projects, and has raised about SGD4.7 million in additional project funding,” said Dr Lily Chan, CEO NUS Enterprise.

Mr Amrin Amin (centre), accompanied by Dr Ho, Associate Professor Wilson Wang Ee Jen (2nd from right) and Professor Jerry Fuh Ying-Hsi (right), while visiting the booths. Photo credit: NAMIC

Mr Amrin Amin (centre), accompanied by Dr Ho, Associate Professor Wilson Wang Ee Jen (2nd from right) and Professor Jerry Fuh Ying-Hsi (right), while visiting the booths. Photo credit: NAMIC

“Additive manufacturing (AM) is a disruptive technology that should be embraced by Singapore’s manufacturing industries”, said Mr Chang Chin Nam, Executive Director (Precision Engineering), EDB. “To support technology development and encourage industry-wide adoption, Singapore has embarked on building AM capabilities within the public and private sectors, both in R&D and workforce training. In close partnership with the National University Health System, AM.NUS will therefore complement Singapore’s AM efforts in the biomedical industry.” MIMS

Read more:
NUS unveils cost-effective, time-savvy CLiKX to treat OME
Singapore government to implement VR in clinical education
5 upcoming medical augmented reality technologies